Healthcare

Healthcare, the world's largest industry, is transforming faster than ever. The focus on outcomes based medicine and optimal health management of populations will result in major seismic shifts. Modernization and reform measures are being employed globally by public and private sector organizations to meet the growing need for healthcare. New technologies are being created, offering enormous promise to improve care delivery.

Our Transformational Health practice serves all key industry stakeholders through partnership models that provide access to high-quality content and our global team of industry experts. The practice includes Visionary Health, Life Sciences, Advanced Medical Technologies and Connected Health, focusing on evolving healthcare technologies and covering the entire industry spectrum

  1. 14 Feb 2020  |  Asia Pacific

    Select Diagnostic Imaging Equipment Market Landscape in Malaysia, Forecast to 2023

    New Budget Allocations, Expansions in Private Sector, and Time to Market on Next-generation Imaging Equipment Opens Up Robust Market Opportunities

    This study presents an analysis of the Malaysian diagnostic imaging equipment market. It provides an in-depth analysis of the current trends, market size, and revenue forecast, and market penetration, market attractiveness, in digital radiography, ultrasound, computed tomography, magnetic resonance imaging, interventional X-ray, and fluoroscopy. M...

    $4,950.00

    Special Price $3,712.50 save 25 %

  2. 07 Feb 2020  |  Asia Pacific

    Malaysian Diabetes Devices Market, Forecast to 2023

    Service Models that Address Affordability are the Preferred Models in this Cost-sensitive Market

    Diabetes is a growing concern globally, with more than 425 million people suffering the world over. Malaysia is no exception. It has a very high prevalence of about 16%; there were an estimated 3.57 million diabetics in the country in 2018. Unfortunately, only about 50% of this population is actually diagnosed, meaning half of those diabetics are d...

    $3,000.00

    Special Price $2,250.00 save 25 %

  3. 07 Feb 2020  |  Asia Pacific

    Thai Diabetes Devices Market, Forecast to 2023

    The Professional Testing Segment will See a High Growth Rate of 10% in this High-cost Device Market

    Diabetes is a growing global concern, with more than 425 million people suffering the world over. Thailand is no exception. It has a high prevalence of about 8%; there were an estimated 4.25 million diabetics in the country in 2018. Unfortunately, only about 56% of this population is actually diagnosed, meaning almost half of those diabetics are di...

    $3,000.00

    Special Price $2,250.00 save 25 %

  4. 06 Feb 2020  |  Asia Pacific

    Indonesian Diabetes Devices Market, Forecast to 2023

    Low Diagnosis Rate of 26% Presents Opportunities to Unlock and Tap in to a Large Market

    Diabetes is a growing concern, with more than 425 million people suffering the world over. Indonesia is no exception. It has high prevalence, of about 7% or an estimated 10.48 million diabetics in the country in 2018. Unfortunately, only about 26% of this population is actually diagnosed, meaning over two-thirds of those diabetics are diagnosed onl...

    $3,000.00

    Special Price $2,250.00 save 25 %

  5. 06 Feb 2020  |  Asia Pacific

    Philippine Diabetes Devices Market, Forecast to 2023

    Universal Healthcare Coverage will Help Boost the Low Diagnosis Rate of 33% and Unlock Market Potential

    Diabetes is a growing concern globally, with more than 425 million people suffering the world over. The Philippines is no exception. It has a high prevalence of diabetes, of about 6% or an estimated 3.8 million diabetics, in 2018. Unfortunately, only about 33% of this population is actually diagnosed, meaning more than two-thirds of those diabetic...

    $3,000.00

    Special Price $2,250.00 save 25 %

  6. 10 Jan 2020  |  Asia Pacific

    Growth Insights on China’s Pharmaceutical Industry, Forecast to 2025

    Expedited Regulatory Reviews, Accompanied by Surging Novel Drug Pipelines and a Realigned Distribution System will Propel the Chinese Pharma Industry

    With over-4000 pharmaceutical players, China is the second largest pharmaceutical industry globally. Although highly fragmented, global pharma and biopharmaceutical players such as Novartis, Novo Nordisk, and AstraZeneca, have a significant hold capturing at least 8-10Percentage of the market. The market being highly dependent on its distributor ne...

    $10,000.00

    Special Price $7,500.00 save 25 %

  7. 15 Dec 2015  |  Asia Pacific

    Analysis of the Medical Imaging Market in Selected ASEAN Countries

    Growth and Trends in CT, MR, PET, and SPECT Modalities

    This research service provides an analysis of the medical imaging market in Indonesia, Malaysia, Singapore, and Thailand. It provides a detailed analysis of current trends, market size, revenue forecasts, and drivers and restraints for the computed tomography (CT), medical resonance (MR), Positron emission tomography (PET), and single-photon emissi...

    $6,000.00

    Special Price $4,500.00 save 25 %

  8. 08 Dec 2015  |  Asia Pacific

    A Product and Pipeline Analysis of the Human Plasma-derived Therapeutics Market

    Launch of Novel Immunoglobulin Products and Increasing Awareness of Therapeutic Options to Drive Double-digit Market Growth

    The Chinese pharmaceutical market is expected to be the third-largest in the world in 2013. This research service analyzes various aspects of the Chinese pharmaceutical market between 2007 and 2016. Rising income, improving healthcare infrastructure, and insurance systems are some factors that drive this market. The study discusses in detail the ma...

    $6,000.00

    Special Price $4,500.00 save 25 %

  9. 11 Nov 2015  |  Asia Pacific

    Asia-Pacific Point-of-Care Testing Market

    Trends, Challenges, and Best Practices for Stakeholders

    Asia-Pacific (APAC) point-of-care testing (POCT) market was worth $2.80 billion in 2014. In hospitals, POC is used more in emergency rooms (ERs), operation theatres (OTs), recovery rooms (RRs), cath labs, and intensive care units (ICU). The rental model in which the cost of the device is borne by the manufacturer while the profit is shared by the h...

    $4,950.00

    Special Price $3,712.50 save 25 %

  10. 26 Oct 2015  |  Asia Pacific

    Asia-Pacific Regulations Driving Innovation in Healthcare

    Innovative Public-Private Initiatives Attracting Investment in Research & Development

    The following article is an abstract of some recent whitepapers developed by Frost & Sullivan on the evolving regulatory policies impacting healthcare in Asia-Pacific (APAC). Government initiatives and incentives in the APAC have resulted in increasing investment in research and development (R&D) in healthcare, while free trade economics across the...

    $1,500.00

    Special Price $1,125.00 save 25 %